Althea installs INOVA H3-5 high-velocity syringe filling line Althea Technologies.

Shabbir Anik, CEO of Althea Technologies. The relative range will be accessible for creation of GMP batches in Q1, 2011.. Althea installs INOVA H3-5 high-velocity syringe filling line Althea Technologies, Inc., a respected provider of manufacturing and development providers for biopharmaceuticals and parenteral drug products, today that it has completed installing a fresh INOVA H3-5 high-speed syringe filling series announced. The expanded capacity complements existing prefilled syringe making for clinical items and allows Althea to provide its clients with medication product in prefilled syringes from early development through commercial source.Our Federal government will continue to guarantee Canadians are covered and safe and that people continue to assist in this devastating outbreak. Canadians can be proud of the attempts we are doing to help fight this outbreak. Today's announcement of another mobile lab and team is another example of actions we are taking.’ Honourable Rona Ambrose, Minister of Health ‘Infectious diseases do not respect borders. This mobile laboratory team will provide pivotal surge capability to our existing team in the field and help our worldwide partners stop the spread of the deadly disease.’ Dr. Gregory Taylor Chief Public Health Officer of Canada.

Bisexual women much more likely to have problems with depression, stress and have a tendency to binge-drink Bisexual women are much more likely than their male counterparts to have problems with stress and depression also to binge-drink, according to a fresh nationwide study led by George Mason University researcher Lisa Lindley.